Gut

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Published Online First: 5 August 2005. doi:10.1136/gut.2004.059824
Gut 2006;55:54-61
Copyright © 2006 BMJ Publishing Group Ltd & British Society of Gastroenterology

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
gut.2004.059824v1
55/1/54    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tanaka, S
Right arrow Articles by Sakamoto, C
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tanaka, S
Right arrow Articles by Sakamoto, C

COLORECTAL CANCER

Monocyte chemoattractant protein 1 and macrophage cyclooxygenase 2 expression in colonic adenoma

S Tanaka, A Tatsuguchi, S Futagami, K Gudis, K Wada, T Seo, K Mitsui, M Yonezawa, K Nagata, S Fujimori, T Tsukui, T Kishida, C Sakamoto

Third Department of Internal Medicine, Nippon Medical School, Tokyo, Japan

Correspondence to:
Correspondence to:
Professor C Sakamoto
Third Department of Internal Medicine, Nippon Medical School, 1-1-5, Sendagi, Bunkyo-ku, Tokyo, 113-8603, Japan; choitsu{at}nms.ac.jp


ABSTRACT
Background and aims: Cyclooxygenase 2 (COX-2) expression in subepithelial macrophages of colorectal adenoma has been suggested as the first in a series of steps leading to colorectal tumorigenesis. We tested the hypothesis that chemokines released from human colorectal adenoma epithelium might be involved in COX-2 expression in macrophages of the lamina propria.

Methods: Endoscopic samples of sporadic colorectal adenomas were tested by enzyme linked immunosorbent assay for chemokines involved in macrophage chemotaxis. Localisation of adenoma macrophage chemoattractant protein 1 (MCP-1) and COX-2 were determined by immunohistochemistry. The effects of MCP-1, in the presence or absence of celecoxib, on COX-2 expression, and prostaglandin (PG) E2 and vascular endothelial growth factor (VEGF) release, were examined in human macrophages isolated from peripheral blood.

Results: MCP-1 levels were markedly higher in adenoma with mild-moderate dysplasia (129.7 (19.9) pg/mg protein) and severe dysplasia (227.9 (35.4) pg/mg protein) than in normal colonic mucosa (55.8 (4.2) pg/mg protein). Other chemokine levels, macrophage inflammatory proteins (MIP)-1{alpha} and MIP-1ß, and the chemokine regulated on activation of normal T cell expressed and secreted (RANTES) did not vary significantly between adenoma and normal mucosa. MCP-1 levels in both adenoma and normal colonic mucosa increased significantly three hours after tissue cultivation in vitro. MCP-1 immunoreactivity was restricted to the adenoma epithelium, with no reactivity seen in adjacent normal epithelial cells. MCP-1 stimulated COX-2 expression and PGE2 and VEGF release in human macrophages. Celecoxib, a selective COX-2 inhibitor, inhibited MCP-1-induced PGE2 and VEGF release in macrophages. Addition of exogenous PGE2 reversed this inhibitory effect on VEGF release, suggesting that MCP-1 in adenoma epithelial cells might be involved in COX-2 expression and subsequent macrophage activation.

Conclusions: MCP-1 in colorectal adenoma epithelial cells might be involved in macrophage migration and COX-2 expression, leading to the subsequent development of colonic adenoma.


Abbreviations: COX-2, cyclooxygenase 2; MCP-1, macrophage chemoattractant protein; PG, prostaglandin; VEGF, vascular endothelial growth factor; RANTES, regulated on activation of normal T cell expressed and secreted; ELISA, enzyme linked immunosorbent assay; MIP, macrophage inflammatory protein; NSAIDs, non-steroidal anti-inflammatory drugs; FAP, familial adenomatous polyposis; H&E, haematoxylin and eosin; PBS, phosphate buffered saline; EDTA, ethylenediaminetetraacetic acid; PMSF, phenylmethylsulfonyl fluoride; FITC, fluorescein isothiocyanate; PBMC, peripheral blood mononuclear cells; FCS, fetal calf serum; LPS, lipopolysaccharide; CHAPS, 3-[(3,cholamidopropyl)-dimethylammonio]-l-propane-sulfonate

Keywords: cyclooxygenase; macrophage chemoattractant protein; adenoma; macrophage




This article has been cited by other articles:


Home page
J. Immunol.Home page
S. Shahrara, A. E. I. Proudfoot, C. C. Park, M. V. Volin, G. K. Haines, J. M. Woods, C. H. Aikens, T. M. Handel, and R. M. Pope
Inhibition of Monocyte Chemoattractant Protein-1 Ameliorates Rat Adjuvant-Induced Arthritis
J. Immunol., March 1, 2008; 180(5): 3447 - 3456.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2006 BMJ Publishing Group Ltd & British Society of Gastroenterology